PhaseBio Pharmaceuticals (PHAS.Q), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary disease, announced today that it has entered into an exclusive licensing…
Latest News
Soma Gold Corp (SOMA.V) drills, mills, and produces gold in Colombia
Quimbaya Gold’s (QIM.C) CEO will buy his stock if you won’t
Salt, hydrogen, or uranium? Atco Mining (ATCO.C) hits all three
Prospera Energy (PEI.V) goes to borrowers again as boe/d drops 20%
Argo Living Soils (ARGO.C) creates carbon rich biochar.. could that be turned into graphene?
Hemostenix (HEMO.V): Bringing back that lovin’ feeling.. and up 400% in a month